Related Experiment Videos
[Oral anticoagulation in symptomatic intracranial stenoses]
Der Nervenarzt
|June 12, 2003
Summary
Oral anticoagulation appears safe for patients with symptomatic intracranial stenosis, with low annual rates of stroke and bleeding. However, its efficacy in preventing further ischemic strokes requires further investigation due to study limitations.
Area of Science:
- Neurology
- Vascular Neurology
- Clinical Pharmacology
Context:
- Symptomatic intracranial stenoses are associated with a higher risk of ischemic stroke.
- Previous studies suggest oral anticoagulation may prevent recurrent strokes, but evidence is limited.
- This therapy is frequently used in clinical practice.
Purpose:
- To evaluate the safety and efficacy of oral anticoagulation in patients with symptomatic intracranial stenosis in a real-world clinical setting.
- To determine the annual rates of ischemic stroke and bleeding complications in this patient group.
Summary:
- A study of 61 patients with symptomatic intracranial stenosis treated with oral anticoagulation found an annual ischemic stroke rate of 3%.
- The annual rates for intracerebral and extracerebral bleeding were less than 1% and 2.6%, respectively.
- No deaths were attributed to oral anticoagulation, suggesting a favorable safety profile.
Impact:
- Oral anticoagulation seems safe for managing symptomatic intracranial stenosis.
- While results suggest potential efficacy, the study's small sample size and design preclude definitive conclusions.
- Further research is needed to confirm the effectiveness of oral anticoagulation for stroke prevention in these patients.